Optigenex (OPGX) Stock Price

Optigenex Price

OTC·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

Over the last 3 years Optigenex grew revenue by 31.7% annually, reaching 687,600.00 USD. For Optigenex, the net margin of -102.2% is up versus -2,444.5% a few years ago.

Optigenex stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Optigenex over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Optigenex stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Optigenex's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Optigenex Stock Price History
DateOptigenex Price
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
12/30/20250.00 USD
8/27/20250.04 USD
Access this data via the Eulerpool API

Optigenex Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
301,000.00 USD
-3.97 M USD
-7.36 M USD
Jan 1, 2007
466,000.00 USD
-1.39 M USD
-2.90 M USD
Jan 1, 2009
687,600.00 USD
-319,500.00 USD
-702,400.00 USD

Optigenex Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 13, 2026, 11:37 PM
 
GROSS INCOMEk USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
200620072009
-1,000.00-1,000.00-1,000.00
-7.00-2.00
-71.43
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Optigenex generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Optigenex retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Optigenex's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Optigenex has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Optigenex's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Optigenex stock margins

The Optigenex margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Optigenex. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Optigenex.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
-403.65 %
-1,318.27 %
-2,444.52 %
Jan 1, 2007
-22.10 %
-298.71 %
-622.10 %
Jan 1, 2009
72.64 %
-46.47 %
-102.15 %

Optigenex Stock Revenue, EBIT, Earnings per Share

The Optigenex earnings per share therefore indicates how much revenue Optigenex has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
451.50 M USD
-5.95 B USD
-11.04 B USD
Jan 1, 2007
699.00 M USD
-2.09 B USD
-4.35 B USD
Jan 1, 2009
206.28 M USD
-95.85 M USD
-210.72 M USD

Optigenex business model & stock analysis

Optigenex Inc. is a US-based company that operates in the health and beauty industry. It was founded in 2004 by a team of experienced entrepreneurs from the healthcare sector. The company's business model focuses on the development and marketing of innovative products based on science, research, and technological advancements. Optigenex has three main divisions: health, wellness, and beauty, each offering a variety of products tailored to meet the specific needs and requirements of consumers. The products offered by Optigenex include dietary supplements, anti-aging products, cosmetics, skincare products, hair products, and general health and well-being products. All products are manufactured in the USA and undergo strict quality controls. Optigenex has received numerous awards and recognition for its products and services in recent years, and it takes pride in being known for its unique products and high quality standards in the industry. The company also places a strong emphasis on research and development, collaborating closely with experts and research institutions to constantly develop new innovations and improved products. Optigenex has an extensive research and development department dedicated solely to the development of new technologies, products, and services. A key component of Optigenex's business model is its partner program, which offers partners the opportunity to market and earn money from its products. The company has developed an extensive training program for its partners to ensure they have all the necessary information and knowledge to build a successful business. Optigenex aims to become a global company that offers its products and services worldwide. The company already has a strong presence in the US and some European countries, and it intends to expand its reach and establish a foothold in other regions of the world in the future. Overall, Optigenex is a leading company in the health and beauty industry. With a wide range of innovative products, a strong focus on research and development, and a dedicated team of professionals and partners, the company strives to maintain and expand its position as a market leader in the industry.

Optigenex SWOT Analysis

Strengths

Optigenex Inc possesses several strengths that contribute to its success in the market. Firstly, the company has a strong portfolio of high-quality products that are reliable and efficient. These products have gained a positive reputation among customers and have helped establish a loyal customer base. Furthermore, Optigenex Inc benefits from a well-established distribution network, allowing for widespread availability of its offerings.

Weaknesses

Despite its strengths, Optigenex Inc also faces certain weaknesses. One major weakness is the company's limited market presence. Optigenex Inc primarily operates within a specific niche, which may limit its growth potential. Additionally, the company could benefit from enhancing its brand awareness and marketing efforts to increase visibility and attract a wider customer base.

Opportunities

In terms of opportunities, Optigenex Inc has the potential to expand its product offerings to cater to a larger market. By diversifying its product line, the company can tap into new customer segments and increase its market share. Furthermore, the growing trend of health and wellness presents an excellent opportunity for Optigenex Inc to develop and promote new products that align with consumer demands.

Threats

Optigenex Inc must also be aware of potential threats that could impact its business. One key threat is the presence of strong competitors in the market. These competitors may have established brand names and larger market shares, making it crucial for Optigenex Inc to continuously innovate and differentiate itself from the competition. Moreover, external factors such as changing regulations or economic instability could pose challenges to the company's operations.

Optigenex Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Optigenex historical P/E ratio, EBIT multiple, and P/S ratio

Optigenex annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Optigenex shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
0.00 Stocks
Jan 1, 2007
0.00 Stocks
Jan 1, 2009
0.00 Stocks

Optigenex stock splits

In Optigenex's history, there have been no stock splits.
Price targets and forecasts for Optigenex are not yet available.

Optigenex Executives and Management Board

DZ

Daniel Zwiren

(56)

President, Chief Executive Officer, Chief Financial Officer

Compensation140,000.00 USD
WW

William Walters

(69)

Chairman of the Board · since 2002

MM

Mr. Michael Mullarkey

(44)

Director

Frequently asked questions about Optigenex

The business model of Optigenex Inc is centered around developing and marketing advanced nutraceutical products. Optigenex Inc focuses on using cutting-edge technologies and scientific research to create supplements that optimize overall health and well-being. The company's products aim to enhance cellular function, improve immune system support, and promote better aging. By utilizing innovative ingredients and formulations, Optigenex Inc strives to deliver high-quality health solutions to consumers.

All fundamentals and in-depth analysis of Optigenex

Our stock analysis for Optigenex stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Optigenex. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.